Challenges and opportunities for faecal microbiota transplantation therapy

Epidemiology and Infection

Volumn 141, Issue 11, 2013, Pages 2235-2242

  Rogers, G B ^a   Bruce, K D ^a  

^a Molecular Microbiology Research Laboratory   (United Kingdom)

Author keywords

Clostridium difficile; diarrhoea; gastrointestinal infections; microbiology

Indexed keywords

METRONIDAZOLE; PROBIOTIC AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CLINICAL EFFECTIVENESS; CLOSTRIDIUM DIFFICILE INFECTION; DONOR SELECTION; DRUG CHOICE; FECAL MICROBIOTA TRANSPLANTATION; FECES ANALYSIS; FECES MICROFLORA; HUMAN; INTESTINE FLORA; MICROBIAL COMMUNITY; NONHUMAN; ORGANISMAL INTERACTION; PATHOGENESIS; POPULATION ABUNDANCE; PSEUDOMEMBRANOUS COLITIS; REVIEW; TRANSPLANTATION; TREATMENT RESPONSE;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FECES; GASTROINTESTINAL TRACT; HUMANS;

EID: 84885031968     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813001362     Document Type: Review

References (62)

1. Savage DC. Microbial ecology of the gastrointestinal tract. Annual Review of Microbiology 1977; 31: 107-133.
2. Rosebury T. Microorganisms Indigenous to Man. New York: McGraw-Hill, 1962, pp. 435.
3. Savage DC. Microbial biota of the human intestine: a tribute to some pioneering scientists. Current Issues in Intestinal Microbiology 2001; 2: 1-15.
4. Gordon JH, Dubos R. The anaerobic bacterial flora of the mouse cecum. Journal of Experimental Medicine 1970; 132: 251-260.
5. Drasar BS, et al. The influence of a diet rich in wheat fibre on the human faecal flora. Journal of Medical Microbiology 1976; 9: 423-431.
6. Holdeman LV, Good IJ, Moore WE. Human faecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress. Applied and Environmental Microbiology 1976; 31: 359-375.
7. Simon GL, Gorbach SL. Intestinal flora in health and disease. Gastroenterology 1984; 86: 174-193.
8. Savage DC, Blumershine RV. Surface-surface associations in microbial communities populating epithelial habitats in the murine gastrointestinal ecosystem: scanning electron microscopy. Infection and Immunity 1974; 10: 240-250.
9. Clarridge 3rd JE. Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clinical Microbiology Reviews 2004; 17: 840-862.
10. Jernberg C, et al. Monitorig of antibiotic-induced alterations in the human intestinal microflora and detection of probiotic strains by use of terminal restriction fragment length polymorphism. Applied and Environmental Microbiology 2005; 71: 501-506.
11. Donskey CJ, et al. Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients. Journal of Microbiological Methods 2003; 54: 249-256.
12. Armougom F, Raoult D. Use of pyrosequencing and DNA barcodes to monitor variations in Firmicutes and Bacteroidetes communities in the gut microbiota of obese humans. BMC Genomics 2008; 9: 576.
13. Dethlefsen L, et al. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biology 2008; 6: 280.
14. Lozupone CA, et al. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489: 220-230.
15. Salminen S, et al. Functional food science and gastrointestinal physiology and function. British Journal of Nutrition 1998; 80 (Suppl. 1): S147-S171.
16. Olszak T, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012; 336: 489-493.
17. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via paneth cells. Proceedings of the National Academy of Sciences USA 2002; 99: 15451-15455.
18. Fukuda S, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011; 469: 543-547.
19. Candela M, et al. Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. International Journal of Food Microbiology 2008; 125: 286-292.
20. Ley RE, et al. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-1023.
21. Kau AL, et al. Human nutrition, the gut microbiome and the immune system. Nature 2011; 474: 327-336.
22. Frank DN, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences USA 2007; 104: 13780-13785.
23. Gonzalez A, et al. The mind-body-microbial continuum. Dialogues in Clinical Neuroscience 2011; 13: 55-62.
24. Lupton JR. Microbial degradation products influence colon cancer risk: the butyrate controversy. Journal of Nutrition 2004; 134: 479-482.
25. Duytschaever G, et al. Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings. Applied and Environmental Microbiology 2011; 77: 8015-8024.
26. Rogers GB, et al. Comparing the microbiota of the cystic fibrosis lung and human gut. Gut Microbes 2010; 1: 85-93.
27. Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clinical Infectious Diseases 2008; 46 (Suppl. 1): S12-S18.
28. Bakken JS, et al. Treating Clostridium difficile infection with faecal microbiota transplantation. Clinical Gastroenterology and Hepatology 2011; 9: 1044-1049.
29. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nature Reviews Microbiology 2009; 7: 526-536.
30. Freeman J, et al. The changing epidemiology of Clostridium difficile infections. Clinical Microbiology Reviews 2010; 23: 529-549.
31. Zar FA, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficileassociated diarrhea, stratified by disease severity. Clinical Infectious Diseases 2007; 45: 302-307.
32. McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. American Journal of Gastroenterology 2002; 97: 1769-1775.
33. Rogers GB, Carroll MP, Bruce KD. Enhancing the utility of existing antibiotics by targeting bacterial behaviour? British Journal of Pharmacology 2012; 165: 845-57.
34. Lawrence SJ, Korzenik JR, Mundy LM. Probiotics for recurrent Clostridium difficile disease. Journal of Medical Microbiology 2005; 54: 905-906.
35. Klein W, Müller R. The minimum protein, the zymogenic symbiosis and generation of microbial protein in the rumen, from nitrous compounds not of proteinaceous origin (an article regarding the biology of the ruminant). Journal of Animal Breeding Biology 1941; 48: 255-276.
36. Eiseman B, et al. Faecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958; 44: 854-859.
37. Schwan A, et al. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet 1983; 2: 845.
38. Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989; 1: 1156-1160.
39. Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nature Reviews Gastroenterology & Hepatology 2011; 9: 88-96.
40. Borody TJ, et al. Bacteriotherapy using fecal flora: toying with human motions. Journal of Clinical Gastroenterology 2004; 38: 475-483.
41. Borody TJ, et al. Treatment of ulcerative colitis using faecal bacteriotherapy. Journal of Clinical Gastroenterology 2003; 37: 42-47.
42. Persky SE, Brandt LJ. Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope. American Journal of Gastroenterology 2000; 95: 3283-3285.
43. Faust G, et al. Treatment of recurrent pseudomembranous colitis with stool transplantation: report of six cases. Canadian Journal of Gastroenterology 2002; 16: A43.
44. Hamilton MJ, et al. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. American Journal of Gastroenterology 2012; 107: 761-767.
45. Bakken JS. Faecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 2009; 15: 285-289.
46. Brandt LJ, Borody TJ, Campbell J. Endoscopic fecal microbiota transplantation: 'first-line' treatment for severe Clostridium difficile infection? Journal of Clinical Gastroenterology 2011; 45: 655-657.
47. Cohen SH, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infection Control and Hospital Epidemiology 2010; 31: 431-455.
48. Khoruts A, et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. Journal of Clinical Gastroenterology 2010; 44: 354-360.
49. Grehan MJ, et al. Durable alteration of the colonic microbiota by the administration of donor fecal flora. Journal of Clinical Gastroenterology 2010; 44: 551-561.
50. Petrof EO, et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome 2013; 1: 3.
51. Nelson KE, et al. A catalog of reference genomes from the human microbiome. Science 2010; 328: 994-999.
52. Verberkmoes NC, et al. Shotgun metaproteomics of the human distal gut microbiota. International Society for Microbial Ecology Journal 2009; 3: 179-189.
53. Jansson J, et al. Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS ONE 2009; 4: e6386.
54. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. Journal of Nutrition 1995; 125: 1401-1412.
55. Roberfroid M, et al. Prebiotic effects: metabolic and health benefits. British Journal of Nutrition 2010; 104: S1-S63.
56. Gibson GR, et al. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutrition Research Reviews 2004; 17: 259-275.
57. Moore WE, Holdeman LV. Human faecal flora: the normal flora of 20 Japanese-Hawaiians. Applied Microbiology 1974; 27: 961-979.
58. Stephen AM, Cummings JH. The microbial contribution to human faecal mass. Journal of Medical Microbiology 1980; 13: 45-56.
59. Qin J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464: 59-65.
60. The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-214.
61. Kelly CP. Fecal microbiota transplantation -an old therapy comes of age. New England Journal of Medicine 2013; 368: 474-475.
62. Kunde S, et al. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. Journal of Pediatriatric Gastroenterology and Nutrition 2013. doi:10.1097/MPG. 0b013e318292fa0d.